AAAAAA
Results: 1-25/43
Authors:
Bensaad, K
Rouillard, D
Soussi, T
Citation: K. Bensaad et al., Regulation of the cell cycle by p53 after DNA damage in an amphibian cell line, ONCOGENE, 20(29), 2001, pp. 3766-3775
Authors:
Yolcu, E
Sayan, BS
Yagci, T
Cetin-Atalay, R
Soussi, T
Yurdusev, N
Ozturk, M
Citation: E. Yolcu et al., A monoclonal antibody against DNA binding helix of p53 protein, ONCOGENE, 20(11), 2001, pp. 1398-1401
Authors:
Jassem, E
Bigda, J
Dziadziuszko, R
Schlichtholz, B
Le Roux, D
Grodzki, T
Rzyman, W
Konopa, K
Poberezna, MM
Dobrzanska, Z
Skokowski, J
Soussi, T
Jassem, J
Citation: E. Jassem et al., Serum p53 antibodies in small cell lung cancer: the lack of prognostic relevance, LUNG CANC, 31(1), 2001, pp. 17-23
Authors:
Soussi, T
Puisieux, A
Citation: T. Soussi et A. Puisieux, Restorative genes - PMS2 (post meiotic segregation increased, S-cerevisiae2), B CANCER, 88(4), 2001, pp. 341-342
Authors:
Soussi, T
Gisselbrecht, S
Blay, JY
Citation: T. Soussi et al., c-Kit, SCFR (stem cell factor receptor) CD117, B CANCER, 88(10), 2001, pp. 939-940
Detection of p73 antibodies in patients with various types of cancer: immunological characterization
Authors:
Tominaga, O
Unsal, K
Zalcman, G
Soussi, T
Citation: O. Tominaga et al., Detection of p73 antibodies in patients with various types of cancer: immunological characterization, BR J CANC, 84(1), 2001, pp. 57-63
Authors:
Beroud, C
Collod-Beroud, G
Boileau, C
Soussi, T
Junien, C
Citation: C. Beroud et al., UMD (Universal Mutation Database): A Generic software to build and analyzelocus-specific databases, HUM MUTAT, 15(1), 2000, pp. 86-94
Authors:
Soussi, T
Dehouche, K
Beroud, C
Citation: T. Soussi et al., p53 website and analysis of p53 gene mutations in human cancer: Forging a link between epidemiology and carcinogenesis, HUM MUTAT, 15(1), 2000, pp. 105-113
Authors:
Soussi, T
Citation: T. Soussi, p53 in cell cycle and apoptosis, M S-MED SCI, 16(4), 2000, pp. 469-472
Authors:
Soussi, T
Dehouche, K
Beroud, C
Citation: T. Soussi et al., Analysis of p53 gene mutations in human cancer: the link between epidemiology and carcinogenesis, M S-MED SCI, 16(12), 2000, pp. 1387-1396
Authors:
Soussi, T
Citation: T. Soussi, Cancer epidemiology: from the description to molecular biology, M S-MED SCI, 16(12), 2000, pp. 1397-1404
Authors:
Zalcman, G
Soussi, T
Citation: G. Zalcman et T. Soussi, Alterations in p53 tumor suppressor gene in lung cancer, REV MAL RES, 17(1), 2000, pp. 329-349
Authors:
Cabelguenne, A
Blons, H
de Waziers, I
Carnot, F
Houllier, AM
Soussi, T
Brasnu, D
Beaune, P
Luccourreye, O
Laurent-Puig, P
Citation: A. Cabelguenne et al., p53 alterations predict tumor response to neoadjuvant chemotherapy in headand neck squamous cell carcinoma: A prospective series, J CL ONCOL, 18(7), 2000, pp. 1465-1473
Authors:
Hammel, P
Soussi, T
Citation: P. Hammel et T. Soussi, Serum p53 antibodies assay: evaluation in colorectal cancer., REV MED IN, 21(2), 2000, pp. 167-173
Authors:
Warnakulasuriya, S
Soussi, T
Maher, R
Johnson, N
Tavassoli, M
Citation: S. Warnakulasuriya et al., Expression of p53 in oral squamous cell carcinoma is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients, J PATHOLOGY, 192(1), 2000, pp. 52-57
Authors:
Portefaix, JM
Thebault, S
Bourgain-Guglielmetti, F
Del Rio, M
Granier, C
Mani, JC
Navarro-Teulon, I
Nicolas, M
Soussi, T
Pau, B
Citation: Jm. Portefaix et al., Critical residues of epitopes recognized by several anti-p53 monoclonal antibodies correspond to key residues of p53 involved in interactions with the mdm2 protein, J IMMUNOL M, 244(1-2), 2000, pp. 17-28
Authors:
Zalcman, G
Tredaniel, J
Schlichtholz, B
Urban, T
Milleron, B
Lubin, R
Meignin, V
Couderc, LJ
Hirsch, A
Soussi, T
Citation: G. Zalcman et al., Prognostic significance of serum p53 antibodies in patients with limited-stage small cell lung cancer, INT J CANC, 89(1), 2000, pp. 81-86
Authors:
Soussi, T
Citation: T. Soussi, p53 antibodies in the sera of patients with various types of cancer: A review, CANCER RES, 60(7), 2000, pp. 1777-1788
Authors:
Soussi, T
Feracci, H
Larue, L
Citation: T. Soussi et al., E-Cadherin (Uvomorulin) or CDH1 - Tumor suppressor protein, B CANCER, 87(9), 2000, pp. 617-618
Authors:
Soussi, T
Piette, J
Citation: T. Soussi et J. Piette, Human double minute 2 (MDM2 in the mouse) - Oncoprotein, B CANCER, 87(9), 2000, pp. 619-620
Authors:
Soussi, T
Citation: T. Soussi, The tumor suppressor gene hSNF5/INI1 (SMARCB1), B CANCER, 87(4), 2000, pp. 295-296
Authors:
Soussi, T
Citation: T. Soussi, BCR (breakpoint cluster region), B CANCER, 87(3), 2000, pp. 229-230
Authors:
Soussi, T
Fuchs, R
Cordonnier, A
Citation: T. Soussi et al., Gene repair - DNA polymerase eta (Pol H) or hRad30A - Foreword, B CANCER, 87(11), 2000, pp. 769-770
Authors:
Soussi, T
Beroud, C
Citation: T. Soussi et C. Beroud, VHL (von Hippel-Lindau) - Tumor suppressor gene, B CANCER, 87(11), 2000, pp. 771-772
Authors:
Murray, PV
Soussi, T
O'Brien, MER
Smith, IE
Brossault, S
Norton, A
Ashley, S
Tavassoli, M
Citation: Pv. Murray et al., Serum p53 antibodies: Predictors of survival in small-cell lung cancer?, BR J CANC, 83(11), 2000, pp. 1418-1424